CDISC Test Study II This file contains test data for the CDISC Connect-A-Thon event scheduled for the DIA 11th Annual European Workshop on Clinical Data Management. CDISC-123-456-789 None Discontinued permanently Reduced Interrupted None Medication required Hospitalization required or prolonged Other Resolved, no residual effects Continuing Resolved, residual effects Death None Unlikely Possible Probable Mild Moderate Severe Life Threatening Treatment A Treatment B Treatment C Source verified, not queried Source verified, queried Normal Abnormal Not Done Head, Neck and Thyroid Eyes, Ears, Nose and Throat Chest Lungs Heart Lymph Nodes Abdomen Anorectal Genitalia Skin Musculoskeletal Neurological Other q.d. b.i.d. t.i.d. q.i.d. q.o.d. q.h.s. cont. IV prn If not in list, record as Other IV IM PO SC PV PR Sublingual Inhaled Topical If not in list United States Female Male Fred Hutchinson Roswell Park Oncology Shirley Williams Shirley Williams CDISC Signature Meaning Legal Reason 20010530T10:06:32 20010530T10:06:32 20010530T10:06:32 20010530T10:06:32 20010530T10:06:32 20010530T10:06:32